Investment House LLC Charles River Laboratories International, Inc. Transaction History

Investment House LLC

  • $1.83 Billion
  • Q3 2024

A detailed history of Investment House LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Investment House LLC holds 68,306 shares of CRL stock, worth $13.4 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
68,306
Previous 68,505 0.29%
Holding current value
$13.4 Million
Previous $14.2 Million 4.92%
% of portfolio
0.74%
Previous 0.81%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$187.96 - $245.29 $37,404 - $48,812
-199 Reduced 0.29%
68,306 $13.5 Million
Q2 2024

Jul 22, 2024
BUY
$206.39 - $268.73 $53,661 - $69,869
260 Added 0.38%
68,505 $14.2 Million
Q1 2024

May 02, 2024
BUY
$203.52 - $273.43 $24,218 - $32,538
119 Added 0.17%
68,245 $18.5 Million
Q4 2023

Feb 05, 2024
SELL
$164.52 - $238.84 $116,151 - $168,621
-706 Reduced 1.03%
68,126 $16.1 Million
Q3 2023

Nov 09, 2023
SELL
$194.44 - $217.61 $1.25 Million - $1.4 Million
-6,411 Reduced 8.52%
68,832 $13.5 Million
Q2 2023

Aug 08, 2023
SELL
$183.71 - $210.25 $766,070 - $876,742
-4,170 Reduced 5.25%
75,243 $15.8 Million
Q1 2023

May 09, 2023
SELL
$191.89 - $259.92 $218,946 - $296,568
-1,141 Reduced 1.42%
79,413 $16 Million
Q4 2022

Feb 07, 2023
SELL
$197.11 - $250.07 $305,520 - $387,608
-1,550 Reduced 1.89%
80,554 $17.5 Million
Q3 2022

Oct 31, 2022
SELL
$182.44 - $250.54 $569,395 - $781,935
-3,121 Reduced 3.66%
82,104 $16.2 Million
Q2 2022

Aug 09, 2022
SELL
$204.13 - $302.4 $1.07 Million - $1.59 Million
-5,255 Reduced 5.81%
85,225 $18.2 Million
Q1 2022

Apr 14, 2022
SELL
$255.51 - $362.11 $254,232 - $360,299
-995 Reduced 1.09%
90,480 $25.7 Million
Q4 2021

Feb 09, 2022
SELL
$351.38 - $448.68 $323,620 - $413,234
-921 Reduced 1.0%
91,475 $34.5 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $231,036 - $284,146
-620 Reduced 0.67%
92,396 $38.1 Million
Q2 2021

Jul 20, 2021
BUY
$294.17 - $371.65 $102,076 - $128,962
347 Added 0.37%
93,016 $34.4 Million
Q1 2021

May 06, 2021
SELL
$249.67 - $299.48 $247,173 - $296,485
-990 Reduced 1.06%
92,669 $26.9 Million
Q4 2020

Jan 13, 2021
BUY
$222.0 - $252.62 $11,322 - $12,883
51 Added 0.05%
93,659 $23.4 Million
Q3 2020

Nov 06, 2020
SELL
$175.56 - $226.45 $64,079 - $82,654
-365 Reduced 0.39%
93,608 $21.2 Million
Q2 2020

Jul 13, 2020
SELL
$118.84 - $189.72 $47,179 - $75,318
-397 Reduced 0.42%
93,973 $16.4 Million
Q1 2020

Apr 08, 2020
SELL
$98.9 - $178.34 $57,164 - $103,080
-578 Reduced 0.61%
94,370 $11.9 Million
Q4 2019

Feb 05, 2020
SELL
$126.05 - $152.76 $281,091 - $340,654
-2,230 Reduced 2.29%
94,948 $14.5 Million
Q3 2019

Nov 12, 2019
BUY
$125.07 - $143.67 $228,252 - $262,197
1,825 Added 1.91%
97,178 $12.9 Million
Q2 2019

Aug 05, 2019
BUY
$123.4 - $148.55 $3,455 - $4,159
28 Added 0.03%
95,353 $13.5 Million
Q1 2019

May 03, 2019
BUY
$104.82 - $146.73 $9,433 - $13,205
90 Added 0.09%
95,325 $13.8 Million
Q4 2018

Feb 06, 2019
BUY
$105.09 - $137.23 $80,393 - $104,980
765 Added 0.81%
95,235 $10.8 Million
Q3 2018

Oct 09, 2018
BUY
$112.11 - $134.54 $68,947 - $82,742
615 Added 0.66%
94,470 $12.7 Million
Q2 2018

Jul 10, 2018
BUY
$102.37 - $117.25 $141,270 - $161,805
1,380 Added 1.49%
93,855 $10.5 Million
Q1 2018

May 08, 2018
BUY
$98.19 - $115.2 $17,674 - $20,736
180 Added 0.2%
92,475 $9.87 Million
Q4 2017

Jan 31, 2018
BUY
$100.43 - $118.09 $5,021 - $5,904
50 Added 0.05%
92,295 $10.1 Million
Q3 2017

Oct 30, 2017
BUY
$96.72 - $109.26 $8.92 Million - $10.1 Million
92,245
92,245 $9.96 Million

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email